Scientific & Technology Consulting

BC Platforms helps life sciences organizations generate high‑quality evidence and build modern data and AI foundations — so you can innovate faster, operate confidently, and scale without risk.

Get started

From complex data to clear answers

Turn to BC Platforms for flexible engagement models that enable rapid time to value, predictable scope, and scalable expansion. Whether you build on our data and technology solutions — or engage us independently — you’ll get the scientific rigor and modern data / AI engineering needed to turn complex healthcare data into robust, actionable insights faster and with less risk. 

Our experience, your advantage

A highly experienced team — bringing decades of hands‑on scientific, clinical, and technical expertise — helps move your projects forward faster and with less risk through consistently high‑quality deliverables.

A consultative, collaborative, outcome‑driven approach

We don’t just deliver services. We build long‑term partnerships grounded in trust and measurable impact through an engagement model that ensures:

• Clear scoping and value definition
• Clear communication
• Repeatable frameworks for efficiency and quality
• On-time delivery
• Strong collaboration with client teams

A partner you can count on 

Our teams combine deep know‑how with reliable delivery and a results‑first mindset, serving as a trusted partner that’s here when you need us.

• Deep scientific, analytics, and AI/technology expertise
• Proven track record
• Measurable outcomes aligned to your goals
• Global scale and delivery
• Flexible and transparent pricing

Delivering real-world results

Oncology study: feasibility to submission

Supported feasibility assessments through submission by harmonizing multi‑modal data, developing study protocols and SAPs, and performing analytics for regulatory milestones.

Technology development

Leveraged partnerships with AWS and NVIDIA to develop scalable technology solutions, including custom development and rapid refactoring of legacy systems.

Market access evidence at scale

Delivered advanced biostatistics and programming to produce benefit dossiers for regulatory submissions.

Rare disease studies for regulatory use

Provided subject‑matter expertise to shape study design, guide data collection, and validate results.

AI‑ready RWE foundation

Built AI‑ready RWE foundations through structured assessments, defined roadmaps, and discovery sprints – then refined and optimized models.

Multi‑modal datasets

Ingested, harmonized, and integrated multi‑modal datasets to power research projects and accelerate drug pipelines.